Heart Disease
Medline Studies
Scientific Studies
Oral EDTA
Competitive Products
Toxic Metals
Main Technical Section For  Chelation Therapy On Line

Vibrant Life Home Web
Family Of Three Chelation Formulas
MSM
Other VL Products
The Wednesday Letter
Frequently Asked Questions
Testimonials
Heart Disease & Bypass Surgery Home Page

Shopping Cart

Separate Search Page
or search below


Navigation Help

Karl Loren Background

Ingredients
Technical
Write To Karl Loren Table Of Contents

31 Studies:  Chemical Interaction with Mercury and EDTA


Results for your query on September 3, 2000:
Search all fields for: mercury And EDTA
Published in 1966 through 1999
Only select references with abstracts available
Show references published in English only
Show references pertaining to humans

Documents: 1 to 31 of 31

1

Top Of Menu

Duhr EF, et al; HgEDTA complex inhibits GTP interactions with the E-site of brain beta-tubulin. (Toxicol Appl Pharmacol, 1993 Oct, Abstract available) [MEDLINE]

2 Kalamegham R, et al; A simple ICP-MS procedure for the determination of total mercury in whole blood and urine. (J Clin Lab Anal, 1992, Abstract available) [MEDLINE]
3 Gonzalvo MC, et al; Inhibition of paraoxonase activity in human liver microsomes by exposure to EDTA, metals and mercurials. (Chem Biol Interact, 1997 Aug, Abstract available) [MEDLINE]
4 Mujica A, et al; Human semen ribonuclease. Location, properties and inhibition by sodium dodecyl sulfate, zinc sulfate and EDTA. (Int J Fertil, 1976, Abstract available) [MEDLINE]
5 Farkas WR, et al; Effects of plumbous ion on guanine metabolism. (J Inorg Biochem, 1979 Aug, Abstract available) [MEDLINE]
6 Guldager B, et al; Metal excretion and magnesium retention in patients with intermittent claudication treated with intravenous disodium EDTA. (Clin Chem, 1996 Dec, Abstract available) [MEDLINE]
7 Duhr EF, et al; HgEDTA complex inhibits GTP interactions with the E-site of brain beta-tubulin. (Toxicol Appl Pharmacol, 1993 Oct, Abstract available) [MEDLINE]
8 Nooijen JL, et al; Trace element studies in three patients and a fetus with Menkes' disease. Effect of copper therapy. (Pediatr Res, 1981 Mar, Abstract available) [MEDLINE]
9 Chau LY, et al; Monoglyceride and diglyceride lipases from human platelet microsomes. (Biochim Biophys Acta, 1988 Dec, Abstract available) [MEDLINE]
10

Menu Position #10

Murata M, et al; Differential metal response and regulation of human heavy metal-inducible genes. (J Cell Physiol, 1999 Jul, Abstract available) [MEDLINE]

11 Araki S, et al; Mobilisation of heavy metals into the urine by CaEDTA: relation to erythrocyte and plasma concentrations and exposure indicators. (Br J Ind Med, 1986 Sep, Abstract available) [MEDLINE]
12 Kumar S, et al; Cyclic adenosine 3':5'-monophosphate phosphodiesterase activity in malignant and cyclic adenosine 3':5'-monophosphate-induced "differentiated" neuroblastoma cells. (Cancer Res, 1975 Jan, Abstract available) [MEDLINE]
13 Mitchell RA, et al; Erythrocyte porphobilinogen synthase (delta-aminolaevulinate dehydratase) activity: a reliable and quantitative indicator of lead exposure in humans. (Clin Chem, 1977 Jan, Abstract available) [MEDLINE]
14 Noma A, et al; Comparative studies on cholesterol oxidases from different sources. (Clin Chim Acta, 1976 Dec, Abstract available) [MEDLINE]
15 Warwas M, et al; Cathepsins B1 from human fetal membranes. (Biochim Biophys Acta, 1976 Apr, Abstract available) [MEDLINE]
16 Dunbabin DW, et al; Lead poisoning from Indian herbal medicine (Ayurveda) [see comments] (Med J Aust, 1992 Dec, Abstract available) [MEDLINE]
17 Alton KB, et al; High-performance liquid chromatographic determination of N-[2(S)-(mercaptomethyl)-3-(2-methylphenyl)-1-oxopropyl]-L-methionine, the active plasma metabolite of a prodrug atriopeptidase inhibitor (SCH 42495), using a thiol selective (Au/Hg) amperometric detector. (J Chromatogr, 1992 Sep, Abstract available) [MEDLINE]
18 Szász I, et al; Phosphorylation of the Ca2+ pump intermediate in intact red cells, isolated membranes and inside-out vesicles. (Mol Cell Biochem, 1978 Dec, Abstract available) [MEDLINE]
19 Margel S; A novel approach for heavy metal poisoning treatment, a model. Mercury poisoning by means of chelating microspheres: hemoperfusion and oral administration. (J Med Chem, 1981 Oct, Abstract available) [MEDLINE]
20

Menu Position #20

Sandborgh Englund G, et al; No evidence of renal toxicity from amalgam fillings [see comments] (Am J Physiol, 1996 Oct, Abstract available) [MEDLINE]

21 Pratt CW, et al; The effect of zinc and other divalent cations on the structure and function of human alpha 2-macroglobulin. (Biochim Biophys Acta, 1984 Dec, Abstract available) [MEDLINE]
22 De Bisschop HC, et al; Stereoselective hydrolysis of soman in human plasma and serum. (Biochem Pharmacol, 1987 Nov, Abstract available) [MEDLINE]
23 Aposhian HV, et al; Mobilization of heavy metals by newer, therapeutically useful chelating agents. (Toxicology, 1995 Mar, Abstract available) [MEDLINE]
24 Hainaut P, et al; A structural role for metal ions in the "wild-type" conformation of the tumor suppressor protein p53. (Cancer Res, 1993 Apr, Abstract available) [MEDLINE]
25 Hainaut P, et al; A structural role for metal ions in the "wild-type" conformation of the tumor suppressor protein p53. (Cancer Res, 1993 Apr, Abstract available) [MEDLINE]
26 ten Bruggenkate CM, et al; Lead poisoning with pigmentation of the oral mucosa. Review of the literature and report of a case. (Oral Surg Oral Med Oral Pathol, 1975 May, Abstract available) [MEDLINE]
27 Teng YS, et al; Human erythrocyte pyrimidine nucleoside monophosphate kinase. Partial purification and properties of two allelic gene products. (J Biol Chem, 1976 Jul, Abstract available) [MEDLINE]
28 Aaseth J; Recent advance in the therapy of metal poisonings with chelating agents. (Hum Toxicol, 1983 Apr, Abstract available) [MEDLINE]
29 Domingo JL; Prevention by chelating agents of metal-induced developmental toxicity. (Reprod Toxicol, 1995 Mar, Abstract available) [MEDLINE]
30

Menu Position #30

Rabel SR, et al; Determination of intracellular levels of 6-mercaptopurine metabolites in erythrocytes utilizing capillary electrophoresis with laser-induced fluorescence detection. (Anal Biochem, 1995 Jan, Abstract available) [MEDLINE]

31 Shatzman AR, et al; Metal-binding characteristics of the parotid salivary protein gustin. (Biochim Biophys Acta, 1980 May, Abstract available) [MEDLINE]


Click here for more information!  

Information on HealthGate.com is not a substitute for professional medical care or advice but should be used only as an aid in understanding current medical knowledge. A physician should always be consulted for any health problem or medical condition.

We subscribe to the HONcode principles
of the Health On the Net Foundation

Send comments to support@healthgate.com
Copyright © 2000 HealthGate® Data Corp. All rights reserved.


     

Record 1 from database: MEDLINE
Return To Top

Title
HgEDTA complex inhibits GTP interactions with the E-site of brain beta-tubulin.
Author
Duhr EF; Pendergrass JC; Slevin JT; Haley BE
Address
Division of Medicinal Chemistry and Pharmaceutics, College of Pharmacy, University of Kentucky Medical Center, Lexington.
Source
Toxicol Appl Pharmacol, 1993 Oct, 122:2, 273-80
Abstract
We have found that EDTA and EGTA complexes of Hg2+, which conventional wisdom has assumed are biologically inert, are potentially injurious to the neuronal cytoskeleton. Tubulin, a major protein component of the neuronal cytoskeleton, is the target of multiple toxicants, including many heavy metal ions. Among the mercurials, inorganic mercuric ion (Hg2+) is one of the most potent inhibitors of microtubule polymerization both in vivo and in vitro. In contrast to other heavy metals, the capacity of Hg2+ to inhibit microtubule polymerization or disrupt formed microtubules cannot be prevented by the addition of EDTA and EGTA, both of which bind Hg2+ with very high affinity. To the contrary, the addition of these two chelating agents potentiates Hg2+ inhibition of tubulin polymerization. Results herein show that HgEDTA and HgEGTA inhibit tubulin polymerization by disrupting the interaction of GTP with the E-site of brain beta-tubulin, an obligatory step in the polymerization of tubulin. Both HgEDTA and HgEGTA, but not free Hg2+, prevented binding of [32P]8N3GTP, a photoaffinity nucleotide analog of GTP, to the E-site and displaced bound [32P]8N3GTP at low micromolar concentrations. This complete inhibition of photoinsertion into the E-site occurred in a concentration- and time-dependent fashion and was specific for Hg2+ complexes of EDTA and EGTA, among the chelating agents tested. Given the ubiquity of Hg2+ in the environment and the widespread use of EDTA in foodstuffs and medicine, these mercury complexes may pose a potentially serious threat to human health and play a role in diseases of the neuronal cytoskeleton.
Language of Publication
English
Unique Identifier
94024905

Return To Top


MeSH Heading (Major)
Brain|*DE/ME; Edetic Acid|*PD; Guanosine Triphosphate|AA/DU/*ME; Mercury|*PD; Tubulin|*DE/ME
MeSH Heading
Affinity Labels|DU; Animal; Azides|DU; Binding Sites|DE; Human; In Vitro; Magnesium|PD; Male; Phosphorus Radioisotopes|DU; Photochemistry; Protein Binding|DE; Rats; Rats, Sprague-Dawley; Support, Non-U.S. Gov't; Support, U.S. Gov't, Non-P.H.S.; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0041-008X
Country of Publication
UNITED STATES

Record 2 from database: MEDLINE
Return To Top

Title
A simple ICP-MS procedure for the determination of total mercury in whole blood and urine.
Author
Kalamegham R; Ash KO
Address
Department of Pathology, University of Utah Medical Center, Salt Lake City 84108.
Source
J Clin Lab Anal, 1992, 6:4, 190-3
Abstract
A simple and sensitive procedure for total mercury in whole blood and urine using inductively coupled plasma-mass spectrometry (ICP-MS) is described. Specimens are prepared by precipitation-extraction with 50% v/v hydrochloric acid containing EDTA and cysteine, centrifuged, and filtered through fritended screening column; the filtrates are directly analyzed by ICP-MS. The method is linear between 2 and 200 micrograms/L in the specimen with an absolute sensitivity of 0.2 microgram/L in the final supernatant. The assay variability at various concentrations (microgram/L) of mercury are as follows: intra-assay whole blood (n = 20)-4.6 +/- 0.6 (c.v. 12.3%), 18.3 +/- 1.1 (c.v. 6.1%), 56.4 +/- 2.8 (c.v. 5.0%); inter-assay whole blood (n = 15)-5.7 +/- 1.0 (c.v. 16.8%), 19.7 +/- 2.7 (c.v. 13.5%), and 50.1 +/- 6.9 (c.v. 13.7%); urine (n = 20)-9.3 +/- 1.2 (c.v. 12.9%), 29.6 +/- 2.2 (c.v. 7.4%). Recovery of organic and inorganic mercury from blood samples ranges from 91.6% to 110.2%. The method is suitable for analysis of total mercury, both organic and inorganic, in whole blood and urine.
Language of Publication
English
Unique Identifier
93019810

Return To Top


MeSH Heading (Major)
Mercury|*BL/*UR; Spectrum Analysis, Mass|*MT/SN
MeSH Heading
Argon; Cysteine; Edetic Acid; Human; Hydrochloric Acid; Methylmercury Compounds|BL/UR; Sensitivity and Specificity

Publication Type
JOURNAL ARTICLE
ISSN
0887-8013
Country of Publication
UNITED STATES

Record 3 from database: MEDLINE
Return To Top

Title
Inhibition of paraoxonase activity in human liver microsomes by exposure to EDTA, metals and mercurials.
Author
Gonzalvo MC; Gil F; Hernández AF; Villanueva E; Pla A
Address
Department of Legal Medicine, Faculty of Medicine, Granada, Spain.
Source
Chem Biol Interact, 1997 Aug, 105:3, 169-79
Abstract
Inhibition of paraoxon hydrolase (paraoxonase) activity by 'in vitro' exposure to EDTA, Mg2+, Co2+, Ba2+, La3+, Zn2+, Cu2+, Hg2+, p-hydroxymercuribenzoate (p-OH-MB) and phenyl mercuric acetate (PMA) was investigated in human liver microsomes. Enzyme activity was totally inhibited by 1 mM EDTA in a time-dependent manner, in contrast to previous data obtained in rat liver where an EDTA-resistant fraction was detected. The possible influence of postmortem changes in these results was checked in a parallel experiment using rat livers with different postmortem intervals. From our results the existence in human liver of an EDTA-resistant fraction cannot be discarded. Ba, La and PMA showed immediate inhibition. By contrast the other compounds tested were time-dependent inhibitors. Ba and Zn showed the highest IC50 values. Cu and mercurials (Hg, p-OH-MB, PMA) were the most potent inhibitors of human liver paraoxonase. Kinetic analysis (Lineweaver-Burk and Dixon plots) indicated that different inhibitors exhibit different inhibition patterns: competitive (EDTA, Ba, La, Cu, p-OH-MB and PMA), non competitive (Zn) and mixed (Hg). The pretreatment of sample with dithiothreitol (DTT) protects against the inhibitory effect of mercurials. Furthermore after inhibition by mercurials the activity was restored by DTT. These results confirmed the essential role of the -SH groups to maintain the catalytic activity of paraoxonase and suggest the existence of two types of -SH groups that could differ in their localization.
Language of Publication
English
Unique Identifier
97437462

Return To Top


MeSH Heading (Major)
Edetic Acid|*PD; Enzyme Inhibitors|*PD; Esterases|*AI/ME; Mercury Compounds|*PD; Metals|*PD; Microsomes, Liver|DE/*EN
MeSH Heading
Animal; Dithiothreitol|PD; Enzyme Activation; Human; Kinetics; Rats; Sulfhydryl Compounds|ME; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0009-2797
Country of Publication
IRELAND

Record 4 from database: MEDLINE
Return To Top

Title
Human semen ribonuclease. Location, properties and inhibition by sodium dodecyl sulfate, zinc sulfate and EDTA.
Author
Mujica A; Romero G; Hernandez Montes H
Address
 
Source
Int J Fertil, 1976, :2, 109-13
Abstract
Optimal conditions were established for RNase activity measurement. The enzyme was measured in human seminal plasma as well as in spermatozoa. Results suggest that sperm enzyme may come from seminal plasma contamination and that RNase may be used as a marker enzyme for seminal plasma contamination. Sodium dodecylsulfate, a reagent utilized to produce the solubilization of the spermatozoa, produced a very strong inhibition of the RNase at low concentrations (530 muM). Zinc sulfate and EDTA also produced inhibition of the RNase activity. Such inhibition may be very useful in future studies of RNA metabolism in human spermatozoa.
Language of Publication
English
Unique Identifier
76259358

Order full text for this document


MeSH Heading (Major)
Edetic Acid|*PD; Ribonucleases|*/ME; Semen|*EN; Sodium Dodecyl Sulfate|*PD; Zinc|*PD
MeSH Heading
Dithiothreitol|PD; Human; Hydrogen-Ion Concentration; Male; Mercury|PD; Spermatozoa|EN

Publication Type
JOURNAL ARTICLE
ISSN
0020-725X
Country of Publication
UNITED STATES

Record 5 from database: MEDLINE
Return To Top

Title
Effects of plumbous ion on guanine metabolism.
Author
Farkas WR; Stanawitz T
Address
 
Source
J Inorg Biochem, 1979 Aug, 11:1, 31-8
Abstract
The enzyme guanine aminohydrolase (guanase) is inhibited by low levels of Pb2+. The inhibition is noncompetitive and the Ki is 3.0 X 10(-6) M. The only other heavy metals that are inhibitory at low concentrations are Ag+, which is 36% more, and Hg2+, which is about 50% less inhibitory than Pb2+. The inhibition of guanase by Pb2+ and Hg2+ is synergistic and the inhibition of the enzyme was readily reversed by EDTA. The relationship of these studies with guanase and to the etiology and treatment of saturnine gout, which appears in humans suffering from lead poisoning, is discussed.
Language of Publication
English
Unique Identifier
80008188

Return To Top


MeSH Heading (Major)
Aminohydrolases|*AI; Guanine Deaminase|*AI; Lead|*PD
MeSH Heading
Cations, Divalent; Edetic Acid|PD; Gout|EN/ET; Human; Kinetics; Lead Poisoning|EN; Mercury|PD; Silver|PD; Support, U.S. Gov't, P.H.S.; Xanthine Oxidase|ME

Publication Type
JOURNAL ARTICLE
ISSN
0162-0134
Country of Publication
UNITED STATES

Record 6 from database: MEDLINE
Return To Top

Title
Metal excretion and magnesium retention in patients with intermittent claudication treated with intravenous disodium EDTA.
Author
Guldager B; J‡rgensen PJ; Grandjean P
Address
Department of Surgery, Hiller‡d Hospital, Denmark.
Source
Clin Chem, 1996 Dec, 42:12, 1938-42
Abstract
Sixty patients with intermittent claudication participated in a double-blind placebo-controlled trial of 20 courses of intravenous chelation therapy with 3 g of disodium EDTA vs placebo during 5-9 weeks. After the first infusion, the 24-h urinary excretion of lead and zinc was approximately 25-fold higher in the EDTA-treated group; relative differences for copper and calcium were smaller. Urinary magnesium excretion in the EDTA-treated group was one-third less than in the control group. After the treatment period, the blood lead concentration had decreased by approximately 73% and the serum zinc concentration by approximately 34%; other changes in blood concentrations were negligible. The loss of essential minerals and the possible redistribution of lead in the body may constitute a disadvantage that should be taken into account in repeated intravenous EDTA treatment.
Language of Publication
English
Unique Identifier
97124459

Return To Top


MeSH Heading (Major)
Edetic Acid|*TU; Intermittent Claudication|*DT/ME; Magnesium|BL/*ME/UR; Metals|*UR
MeSH Heading
Adult; Aged; Aged, 80 and over; Calcium|UR; Copper|BL/UR; Double-Blind Method; Human; Lead|BL/UR; Mercury|BL; Middle Age; Placebos; Support, Non-U.S. Gov't; Zinc|BL/UR

Publication Type
CLINICAL TRIAL; JOURNAL ARTICLE; RANDOMIZED CONTROLLED TRIAL
ISSN
0009-9147
Country of Publication
UNITED STATES

Record 7 from database: MEDLINE
Return To Top

Title
HgEDTA complex inhibits GTP interactions with the E-site of brain beta-tubulin.
Author
Duhr EF; Pendergrass JC; Slevin JT; Haley BE
Address
Division of Medicinal Chemistry and Pharmaceutics, College of Pharmacy, University of Kentucky Medical Center, Lexington.
Source
Toxicol Appl Pharmacol, 1993 Oct, 122:2, 273-80
Abstract
We have found that EDTA and EGTA complexes of Hg2+, which conventional wisdom has assumed are biologically inert, are potentially injurious to the neuronal cytoskeleton. Tubulin, a major protein component of the neuronal cytoskeleton, is the target of multiple toxicants, including many heavy metal ions. Among the mercurials, inorganic mercuric ion (Hg2+) is one of the most potent inhibitors of microtubule polymerization both in vivo and in vitro. In contrast to other heavy metals, the capacity of Hg2+ to inhibit microtubule polymerization or disrupt formed microtubules cannot be prevented by the addition of EDTA and EGTA, both of which bind Hg2+ with very high affinity. To the contrary, the addition of these two chelating agents potentiates Hg2+ inhibition of tubulin polymerization. Results herein show that HgEDTA and HgEGTA inhibit tubulin polymerization by disrupting the interaction of GTP with the E-site of brain beta-tubulin, an obligatory step in the polymerization of tubulin. Both HgEDTA and HgEGTA, but not free Hg2+, prevented binding of [32P]8N3GTP, a photoaffinity nucleotide analog of GTP, to the E-site and displaced bound [32P]8N3GTP at low micromolar concentrations. This complete inhibition of photoinsertion into the E-site occurred in a concentration- and time-dependent fashion and was specific for Hg2+ complexes of EDTA and EGTA, among the chelating agents tested. Given the ubiquity of Hg2+ in the environment and the widespread use of EDTA in foodstuffs and medicine, these mercury complexes may pose a potentially serious threat to human health and play a role in diseases of the neuronal cytoskeleton.
Language of Publication
English
Unique Identifier
94024905

Return To Top


MeSH Heading (Major)
Brain|*DE/ME; Edetic Acid|*PD; Guanosine Triphosphate|AA/DU/*ME; Mercury|*PD; Tubulin|*DE/ME
MeSH Heading
Affinity Labels|DU; Animal; Azides|DU; Binding Sites|DE; Human; In Vitro; Magnesium|PD; Male; Phosphorus Radioisotopes|DU; Photochemistry; Protein Binding|DE; Rats; Rats, Sprague-Dawley; Support, Non-U.S. Gov't; Support, U.S. Gov't, Non-P.H.S.; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0041-008X
Country of Publication
UNITED STATES

Record 8 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Trace element studies in three patients and a fetus with Menkes' disease. Effect of copper therapy.
Author
Nooijen JL; De Groot CJ; Van den Hamer CJ; Monnens LA; Willemse J; Niermeijer MF
Address
 
Source
Pediatr Res, 1981 Mar, 15:3, 284-9
Abstract
This paper reports the results of a multielement analysis of postmortem samples of Menkes patients, of which one was untreated and two had been treated for various lengths of time with intramuscular injections of copper-EDTA. The findings have been compared with data from a Menkes fetus and from controls. The results confirm that copper accumulates in various tissues and demonstrate a further increase in copper levels as a result of the treatment with copper-EDTA. Although no clinical improvement was observed, the levels of some copper-containing enzymes normalized during the copper-therapy. Furthermore, in agreement with the identification of the copper-binding protein in the kidney as metallothionein, it was found that not only copper, but also zinc, cadmium, and mercury are trapped in this tissue. A low copper concentration in the brain was also found in a Menkes fetus, indicating that brain damage might already have occurred before birth. Speculation Until recently, Menkes' disease was considered to be due to copper deficiency. However, the symptoms are more typical of a storage disease in which copper is irreversibly trapped in some tissues, in particular in the kidneys, by metallothionein. This abnormal storage pattern gives rise to copper deficiency elsewhere in the organism, particularly in the brain where it may cause irreversible damage in the foetus. Parenteral administration of copper does not lead to clinical improvement. The only "therapy" that seems feasible at present is tracing the carriers of the disease and advising abortion when prenatal diagnosis indicates a male fetus carrying the disease.
Language of Publication
English
Unique Identifier
81174435

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Brain Diseases, Metabolic|*DT; Copper|AN/*TU; Menkes Kinky Hair Syndrome|DI/*DT; Trace Elements|*AN
MeSH Heading
Arsenic|AN; Cadmium|AN; Case Report; Cobalt|AN; Comparative Study; Edetic Acid; Female; Fetal Diseases|DI; Human; Infant; Iron|AN; Male; Mercury|AN; Molybdenum|AN; Pregnancy; Selenium|AN; Tissue Distribution; Zinc|AN

Publication Type
JOURNAL ARTICLE
ISSN
0031-3998
Country of Publication
UNITED STATES

Record 9 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Monoglyceride and diglyceride lipases from human platelet microsomes.
Author
Chau LY; Tai HH
Address
Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, University of Kentucky, Lexington 405367-0082.
Source
Biochim Biophys Acta, 1988 Dec, 963:3, 436-44
Abstract
In the present study, we have characterized the properties of both diglyceride lipase (lipoprotein lipase, EC 3.1.1.24) and monoglyceride lipases (acylglycerol lipase, EC 3.1.1.23) in an attempt to assess the potential roles of these two enzymes in the release of arachidonate in activated human platelets. Diglyceride lipase exhibited maximal activity at pH 3.5, whereas monoglyceride lipase showed optimal activity at pH 7.0. Neither of the lipases were inhibited by EDTA or stimulated by Ca2+, Mg2+ or Mn2+. Both enzymes, however, were strongly inhibited by Hg2+ and Cu2+, indicating the involvement of sulfhydryl groups in catalytic activity. This suggestion was further supported by their sensitivity toward sulfhydryl inhibitors, with monoglyceride lipase being more susceptible to inhibition. Both lipases were found to be inhibited to a different degree by a variety of antiplatelet drugs blocking aggregation and arachidonate release. Kinetic studies indicated that dichotomous metabolism of diacylglycerol to monoacylglycerol and to phosphatidic acid could occur concurrently, since the apparent Km values for diglyceride lipase and for diglyceride kinase were comparable. Further studies showed that the specific activity of monoglyceride lipase was at least 100-fold higher than that of diglyceride lipase, indicating that the rate-limiting step in the release of arachidonate was the reaction catalyzed by diglyceride lipase.
Language of Publication
English
Unique Identifier
89062521

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Blood Platelets|*EN; Carboxylic Ester Hydrolases|*BL; Lipoprotein Lipase|*BL; Monoacylglycerol Lipases|*BL
MeSH Heading
Calcium|PD; Copper|PD; Edetic Acid|PD; Heat; Human; Hydrogen-Ion Concentration; Kinetics; Magnesium|PD; Manganese|PD; Mercury|PD; Microsomes|EN; Platelet Aggregation Inhibitors|PD; Substrate Specificity; Sulfhydryl Reagents|PD; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0006-3002
Country of Publication
NETHERLANDS

Record 10 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Differential metal response and regulation of human heavy metal-inducible genes.
Author
Murata M; Gong P; Suzuki K; Koizumi S
Address
Division of Hazard Assessment, National Institute of Industrial Health, Kawasaki, Japan.
Source
J Cell Physiol, 1999 Jul, 180:1, 105-13
Abstract
A number of heavy metal-inducible genes have been reported, but their ranges of response to various metal species are not well known. It is also unclear if these genes are regulated through common mechanisms. To answer these questions, we compared induction kinetics of human metal-inducible genes including the MT-IIA (coding for a metallothionein isoform), hsp70 (coding for the 70-kDa heat-shock protein), and c-fos genes in HeLa cells exposed to Zn, Cd, Ag, Hg, Cu(II), Co, or Ni ions. Transcripts from these three genes were increased after exposure to wide ranges of metals, but each gene was unique in its induction kinetics. Generally, induction was observed at lower metal concentrations in the order of MT-IIA, hsp70, and c-fos. These genes also showed differential responses in time course: more rapid induction was observed in the order of c-fos, hsp70, and MT-IIA after exposure to Zn or Cd. Since the metal-responsive element (MRE) and heat shock element (HSE) of the MT-IIA and hsp70 genes, respectively, are thought to be the cis-acting DNA elements that mediate metal response, we compared the properties of proteins that specifically bind to these elements. MRE-binding activity was detected only in the extract from cells exposed to Zn. By contrast, HSE-binding activity was detected in extracts from cells treated with Zn, Cd, Ag, and Cu. The former was also activated by Zn in vitro, while the latter was not. Each of these DNA-binding activities showed no affinity to the recognition sequence of the other. These results demonstrate that the human metal-inducible genes have broad ranges of response to a variety of heavy metals, but suggest that they are probably regulated through independent mechanisms.
Language of Publication
English
Unique Identifier
99288869

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Heat-Shock Proteins 70|*GE; Metallothionein|*GE; Metals, Heavy|*PD; Proto-Oncogene Proteins c-fos|*GE
MeSH Heading
Blotting, Northern; Cadmium|PD; Chelating Agents|PD; Cobalt|PD; Copper|PD; Dose-Response Relationship, Drug; DNA-Binding Proteins|ME; Edetic Acid|PD; Gene Expression|DE; Gold|PD; Hela Cells; Human; Mercury|PD; Nickel|PD; Nuclear Proteins|ME; Oligonucleotide Probes; RNA, Messenger|AN; Transcription Factors|ME; Transcription, Genetic|PH; Zinc|PD

Publication Type
JOURNAL ARTICLE
ISSN
0021-9541
Country of Publication
UNITED STATES

Record 11 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Mobilisation of heavy metals into the urine by CaEDTA: relation to erythrocyte and plasma concentrations and exposure indicators.
Author
Araki S; Aono H; Murata K
Address
 
Source
Br J Ind Med, 1986 Sep, 43:9, 636-41
Abstract
To investigate the effects of calcium disodium ethylenediamine tetra-acetate (CaEDTA) on the urinary excretion, erythrocyte, and plasma concentrations and exposure indicators of seven heavy metals, CaEDTA was administered by intravenous infusion to 20 workers exposed to lead, zinc, and copper. The workers' blood lead concentrations ranged from 22 to 59 micrograms/dl (mean 38 micrograms/dl (1.8 mumol/l]. The 24 hour urinary excretion of metals after CaEDTA administration (mobilisation yield) was on average 13 times the background excretion for lead, 11 times for zinc, 3.8 times for manganese, 3.4 times for cadmium, 1.3 times for copper, and 1.1 times for chromium; no significant increase was found for mercury. The mobilisation yield of lead (MPb) was significantly correlated with whole blood and erythrocyte concentrations and the urinary excretion of lead but not with its plasma concentration; similarly, the mobilisation yield of cadmium was significantly correlated with its erythrocyte concentration. In addition, MPb was significantly correlated with intra-erythrocytic enzyme delta-aminolaevulinic acid dehydratase activity and urinary coproporphyrin excretion. The relation between the mobilisation yield of heavy metals and their body burden (and toxic signs) is discussed in the light of these findings.
Language of Publication
English
Unique Identifier
87000506

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Edetic Acid|*PD; Erythrocytes|*ME; Metals|*ME
MeSH Heading
Adult; Cadmium|ME; Chromium|ME; Copper|ME; Environmental Exposure; Human; Lead|ME; Male; Manganese|ME; Mercury|ME; Middle Age; Zinc|ME

Publication Type
JOURNAL ARTICLE
ISSN
0007-1072
Country of Publication
ENGLAND

Record 12 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Cyclic adenosine 3':5'-monophosphate phosphodiesterase activity in malignant and cyclic adenosine 3':5'-monophosphate-induced "differentiated" neuroblastoma cells.
Author
Kumar S; Becker G; Prasad KN
Address
 
Source
Cancer Res, 1975 Jan, 35:1, 82-7
Abstract
The regulation of cyclic adenosine 3:5-monophosphate (cyclic AMP) phosphodiesterase activity in homogenates of malignant and cyclic AMP-induced "differentiated" neuroblastoma cells was studied. Neuroblastoma cells of at least three mouse and one human clone had both the low (2 to 4 muM) and the high (66 to 106 muM) Km phosphodiesterase. In cyclic AMP-induced differentiated cells the values of Km were decreased, whereas the values of Vmax appeared to be slightly increased. Magnesium and manganese stimulated phosphodiesterase activity. Calcium, zinc, copper, mercury, ethylenediaminetetraacetic acid, and imidazole completely inhibited phosphodiesterase activity in malignant cells, whereas the above agents, except ethylenediaminetetraacetic acid, only partially inhibited enzyme activity in differentiated cells. Ethylenediaminetetraacetic acid completely reduced phosphodiesterase activity in differentiated cells. The pH optimum for phosphodiesterase activity was about 8 in both malignant and differentiated cells. The present studies show that the values of Km and Vmax and the sensitivity of phosphodiesterase activity to divalent ions change in cyclic AMP-induced differentiated neuroblastoma cells, and therefore we propose that the reverse may be true during malignant transformation of nerve cells.
Language of Publication
English
Unique Identifier
75074120

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Cell Differentiation|*; Cyclic AMP|ME/*PD; Neuroblastoma|*EN; Phosphoric Diester Hydrolases|*ME
MeSH Heading
Adenylate Cyclase|ME; Animal; Calcium|PD; Caudate Nucleus|EN; Clone Cells; Copper|PD; Depression, Chemical; Edetic Acid|PD; Human; Hydrogen-Ion Concentration; Imidazoles|PD; Magnesium|PD; Manganese|PD; Mercury|PD; Mice; Stimulation, Chemical; Support, U.S. Gov't, Non-P.H.S.; Time Factors; Zinc|PD

Publication Type
JOURNAL ARTICLE
ISSN
0008-5472
Country of Publication
UNITED STATES

Record 13 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Erythrocyte porphobilinogen synthase (delta-aminolaevulinate dehydratase) activity: a reliable and quantitative indicator of lead exposure in humans.
Author
Mitchell RA; Drake JE; Wittlin LA; Rejent TA
Address
 
Source
Clin Chem, 1977 Jan, 23:1, 105-11
Abstract
We assessed optimal conditions for assay of porphobillinogen synthase (EC 4.2.1.24) activity in human blood containing abnormally high concentrations of lead. Zn2+and -SH, both required for complete activation of the enzyme, had additive effects. Using a modified method based on these studies, we found blood lead concentration to be strictly proportional to ln(activated/nonactivated) enzyme activity. One brand of commercially available "lead-free" tubes contained a substance that interfered with this relationship. In vitro studies, with the modified assay, showed ALAD to be activated by low concentrations but inactivated by high concentrations of Hg2+, Cd2+, and ethylenediaminetetraacetate. We fouund no genetically influenced differences among unexposed individuals when in(activated/nonactivated) enzyme activities were compared. The technique is suitable for use in screening for lead poisoning in humans.
Language of Publication
English
Unique Identifier
77089786

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Erythrocytes|*EN; Hydro-Lyases|*BL; Lead Poisoning|*DI/*EN; Porphobilinogen Synthase|*BL
MeSH Heading
Cadmium|PD; Edetic Acid|PD; Enzyme Activation|DE; Glutathione|PD; Human; Kinetics; Lead|BL/PD; Mercury|PD; Sodium|PD; Zinc|PD

Publication Type
JOURNAL ARTICLE
ISSN
0009-9147
Country of Publication
UNITED STATES

Record 14 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Comparati